Our Partners

The primary mission of the MPN Research Foundation is to stimulate original research in pursuit of new treatments -- and eventually a cure -- for polycythemia vera, essential thrombocythemia and myelofibrosis, known collectively as myeloproliferative neoplasms (MPN). In addition, the MPN Research Foundation promotes collaboration in the scientific community to accelerate research, and serves as a powerful advocacy group for patients and their families.

Aptel Research (www.aptelresearch.com) is a strategic specialty marketing research and consulting company, specializing in the life sciences industry. Aptel Research is dedicated to helping healthcare companies understand and integrate the experiences and needs of patients and physicians with cutting-edge science in order to create patient-centric products and services.

Published quarterly by the American Association for Cancer Research, Cancer Today magazine empowers patients, survivors and caregivers with reliable, reader-friendly reporting on the latest advances in cancer research, insider looks at people driving progress against cancer, guidance on being an active partner in one’s treatment, and more. Cancer Today’s free monthly e-newsletter contains links to web exclusives, information about events and resources, and magazine highlights

AACCl's Lab Tests Online is an award-winning health information web resource designed to help patients and caregivers understand the many lab tests that are vital part of medical care. Laboratory professionals, who are experts in the field, develop and review all content, including articles on lab tests, conditions/diseases, screening,clinical laboratory topics, and lab test news. The site is produced by AACC, a global scientific and medical professional organization dedicated to clinical laboratory science and its application to healthcare. Learn more.

The Patient Access Network Foundation is an independent, nationwide 501 (c) (3) organization dedicated to providing help and hope to underinsured patients who are unable to afford the out-of-pocket expenses for their prescribed medications. Since 2004, PAN has provided more than 420,000 underinsured patients with over $880 million dollars in much needed financial assistance to cover out-of-pocket medical expenses across nearly 60 disease-specific programs.

Our mission is to fortify the health care consumer with the knowledge and tools to feel more confident playing a central role in decisions that affect their health, putting them more in control of their health and health care.

The National Organization for Rare Disorders (NORD), a 501(c)(3) organization, is a unique federation of voluntary health organizations dedicated to helping people with rare "orphan" diseases and assisting the organizations that serve them. NORD is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and service.

The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. MD Anderson is one of only 41 comprehensive cancer centers designated by the National Cancer Institute (NCI). For ten of the past 12 years, including 2013, MD Anderson has ranked No. 1 in cancer care in “Best Hospitals,” a survey published annually in U.S. News & World Report. MD Anderson receives a cancer center support grant from the NCI of the National Institutes of Health.

The US Oncology Network is one of the nation’s largest networks of integrated, community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. A physician-led organization, The US Oncology Network unites like-minded physicians and clinicians around a common vision of improving patient outcomes and quality of life. Leveraging healthcare information technology, shared best practices, evidence-based guidelines and quality measurements, physicians within The US Oncology Network are pioneering new ways to achieve this vision. The US Oncology Network is committed to strengthening patient access to integrated care in local communities across the nation, including collaboration with a variety of payers, hospitals and academic institutions. The US Oncology Network is supported by McKesson Specialty Health, a division of McKesson Corporation focused on empowering a vibrant and sustainable community patient care delivery system. For more information, visit www.usoncology.com


Page last updated on May 11, 2017
<